Literature DB >> 29122333

Translation and Validation of the Multidimensional Dyspnea-12 Questionnaire.

Carlos Antonio Amado Diago1, Luis Puente Maestu2, Beatriz Abascal Bolado3, Juan Agüero Calvo4, Mercedes Hernando Hernando4, Irene Puente Bats5, Ramón Agüero Balbín6.   

Abstract

INTRODUCTION: Dyspnea is a multidimensional symptom, but this multidimensionality is not considered in most dyspnea questionnaires. The Dyspnea-12 takes a multidimensional approach to the assessment of dyspnea, specifically the sensory and the affective response. The objective of this study was to translate into Spanish and validate the Dyspnea-12 questionnaire.
METHODS: The original English version of the Dyspnea-12 questionnaire was translated into Spanish and backtranslated to analyze its equivalence. Comprehension of the text was verified by analyzing the responses of 10 patients. Reliability and validation of the questionnaire were studied in an independent group of COPD patients attending the pulmonology clinics of Hospital Universitario Marqués de Valdecilla, diagnosed and categorized according to GOLD guidelines.
RESULTS: The mean age of the group (n=51) was 65 years and mean FEV1 was 50%. All patients understood all questions of the translated version of Dyspnea-12. Internal consistency of the questionnaire was α=0.937 and intraclass correlation coefficient was=.969; P<.001. Statistically significant correlations were found with HADS (anxiety r=.608 and depression r=.615), mMRC dyspnea (r=.592), 6MWT (r=-0.445), FEV1 (r=-0.312), all dimensions of CRQ-SAS (dyspnea r=-0.626; fatigue r=-0.718; emotional function r=-0.663; mastery r=-0.740), CAT (r=0.669), and baseline dyspnea index (r=-0.615). Dyspnea-12 scores were 10.32 points higher in symptomatic GOLD groups (B and D) (P<.001).
CONCLUSION: The Spanish version of Dyspnea-12 is a valid and reliable instrument to study the multidimensional nature of dyspnea.
Copyright © 2017 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; Disnea; Disnea-12; Dyspnea; Dyspnea-12; Enfermedad pulmonar obstructiva crónica; Español; Spanish; Validación; Validation

Mesh:

Year:  2017        PMID: 29122333     DOI: 10.1016/j.arbres.2017.08.001

Source DB:  PubMed          Journal:  Arch Bronconeumol (Engl Ed)        ISSN: 0300-2896            Impact factor:   4.872


  3 in total

1.  Therapeutic pulmonary telerehabilitation protocol for patients affected by COVID-19, confined to their homes: study protocol for a randomized controlled trial.

Authors:  Juan Jose Gonzalez-Gerez; Carlos Bernal-Utrera; Ernesto Anarte-Lazo; Jose Antonio Garcia-Vidal; Jose Martin Botella-Rico; Cleofas Rodriguez-Blanco
Journal:  Trials       Date:  2020-06-29       Impact factor: 2.279

2.  The impact of an Education-Based Intervention Program (EBIP) on dyspnea and chronic self-care management among chronic obstructive pulmonary disease patients. A randomized controlled study.

Authors:  Ayse Cevirme; Gonul Gokcay
Journal:  Saudi Med J       Date:  2020-12       Impact factor: 1.484

3.  Do patients with and survivors of COVID-19 benefit from telerehabilitation? A meta-analysis of randomized controlled trials.

Authors:  Jiapeng Huang; Ye Fan; Kehong Zhao; Chunlan Yang; Ziqi Zhao; Yin Chen; Jiaen Yang; Tingting Wang; Yun Qu
Journal:  Front Public Health       Date:  2022-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.